FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors
Hall Render
OCTOBER 5, 2023
Food and Drug Administration (“FDA”) finalized “ Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors ” (“Final Guidance”), following the FDA’s earlier issuance of draft guidance on the subject in July 2014. study sponsor, regulatory agencies, etc.) On August 15, 2023, the U.S.
Let's personalize your content